Lite Strategy LITS
NASDAQ LITS
$1.03 +0.09 (+9.18%)
As of: Aug 21, 2026 · 3:33 PM EDT

Lite Strategy (LITS) Receivables (2021 - 2023)

Lite Strategy (LITS) posted quarterly Receivables of $85000.0 for Q2 2023, down 99.15% year-over-year from $10.0 million in Q2 2022, and down 99.15% quarter-over-quarter from $10.0 million in Q2 2022.

Lite Strategy (LITS) Receivables (2021 - 2023) Analysis & Trends

Lite Strategy's Receivables history runs 3 years deep, the most recent figure standing at $85000.0 for Q2 2023.

  • In Q2 2023, Receivables fell 99.15% year-over-year to $85000.0; the TTM figure through Jun 2023 stood at $85000.0 (down 99.15% YoY), while the FY2023 annual figure was $85000.0, down 99.15% from the prior year.
  • Receivables for Q2 2023 stood at $85000.0, down from $10.0 million in the prior quarter.
  • The five-year high for Receivables was $18.1 million in Q3 2021, with the low at $85000.0 in Q2 2023.
  • The 3-year median for Receivables is $8.8 million (2021), against an average of $9.0 million.
  • The sharpest annual moves came in 2022 and 2023: Receivables surged 32.47% in 2022, then sank 99.15% in 2023.
  • Lite Strategy's Receivables stood at $18.1 million in 2021, then plunged by 44.57% to $10.0 million in 2022, then tumbled by 99.15% to $85000.0 in 2023.
  • Business Quant data shows LITS's Receivables at $85000.0 in Q2 2023, $10.0 million in Q2 2022, and $18.1 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 138.83 Bn 130.98 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 85.79 Bn 77.79 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 64.95 Bn 59.77 Bn 1.37 Bn 1.93 Bn
4 Moderna 58.59 Bn 53.46 Bn 52.00 Mn 160.00 Mn
5 BeOne Medicines 41.93 Bn 36.83 Bn 1.53 Bn 1.06 Bn
6 Alnylam Pharmaceuticals 31.52 Bn 28.21 Bn 992.69 Mn 912.74 Mn
7 BioNTech SE 27.98 Bn 9.58 Bn 668.28 Mn 1.09 Bn
8 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 215.33 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn - -
10 Lite Strategy 36.78 Mn 29.24 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 85,000.00
Jun 30, 2022 10.04 Mn
Sep 30, 2021 18.12 Mn
Jun 30, 2021 7.58 Mn